Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | ubiquitin-conjugating enzyme e2, putative | 0.0037 | 0.5407 | 0.5 |
Echinococcus multilocularis | ubiquitin conjugating enzyme E2 N | 0.0037 | 0.5407 | 0.5407 |
Echinococcus granulosus | FTZ F1 alpha | 0.001 | 0.0297 | 0.0297 |
Brugia malayi | Ubiquitin conjugating enzyme protein 13 | 0.0037 | 0.5407 | 0.5267 |
Schistosoma mansoni | RAR-like nuclear receptor | 0.001 | 0.0297 | 0.0297 |
Schistosoma mansoni | thyroid hormone receptor | 0.001 | 0.0297 | 0.0297 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.001 | 0.0297 | 0.5 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0037 | 0.5407 | 0.5267 |
Plasmodium vivax | ubiquitin-conjugating enzyme E2 N, putative | 0.0037 | 0.5407 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0044 | 0.6792 | 0.6792 |
Toxoplasma gondii | ubiquitin-conjugating enzyme subfamily protein | 0.0037 | 0.5407 | 0.5 |
Echinococcus granulosus | FTZ F1 nuclear receptor protein | 0.001 | 0.0297 | 0.0297 |
Plasmodium falciparum | ubiquitin-conjugating enzyme E2 N, putative | 0.0037 | 0.5407 | 0.5 |
Schistosoma mansoni | photoreceptor-specific nuclear receptor related | 0.001 | 0.0297 | 0.0297 |
Echinococcus granulosus | COUP TF:Svp nuclear hormone receptor | 0.001 | 0.0297 | 0.0297 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.001 | 0.0297 | 0.5 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.001 | 0.0297 | 0.0297 |
Echinococcus granulosus | ecdysone induced protein 78C | 0.001 | 0.0297 | 0.0297 |
Schistosoma mansoni | nuclear hormone receptor nor-1/nor-2 | 0.001 | 0.0297 | 0.0297 |
Echinococcus multilocularis | ecdysone induced protein 78C | 0.001 | 0.0297 | 0.0297 |
Schistosoma mansoni | nuclear hormone receptor | 0.001 | 0.0297 | 0.0297 |
Schistosoma mansoni | ubiquitin conjugating enzyme 13 | 0.0037 | 0.5407 | 0.5407 |
Echinococcus multilocularis | FTZ F1 alpha | 0.001 | 0.0297 | 0.0297 |
Onchocerca volvulus | 0.001 | 0.0297 | 0.5 | |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.001 | 0.0297 | 0.0297 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.001 | 0.0297 | 0.0297 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0044 | 0.6792 | 0.6693 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.001 | 0.0297 | 0.0297 |
Echinococcus multilocularis | FTZ F1 nuclear receptor protein | 0.001 | 0.0297 | 0.0297 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0044 | 0.6792 | 0.6792 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0044 | 0.6792 | 0.6792 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0037 | 0.5407 | 0.5267 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0044 | 0.6792 | 0.6792 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0044 | 0.6792 | 0.6792 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0037 | 0.5407 | 0.5 |
Schistosoma mansoni | thyroid hormone receptor | 0.001 | 0.0297 | 0.0297 |
Schistosoma mansoni | FTZ-F1 nuclear receptor-like protein | 0.001 | 0.0297 | 0.0297 |
Echinococcus granulosus | ubiquitin conjugating enzyme E2 N | 0.0037 | 0.5407 | 0.5407 |
Echinococcus granulosus | Nuclear hormone receptor family member nhr 41 | 0.001 | 0.0297 | 0.0297 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0037 | 0.5407 | 1 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.001 | 0.0297 | 0.0297 |
Echinococcus multilocularis | Nuclear hormone receptor family member nhr 41 | 0.001 | 0.0297 | 0.0297 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0044 | 0.6792 | 0.6693 |
Schistosoma mansoni | retinoid-x-receptor (RXR) | 0.001 | 0.0297 | 0.0297 |
Echinococcus multilocularis | COUP TF:Svp nuclear hormone receptor | 0.001 | 0.0297 | 0.0297 |
Echinococcus granulosus | retinoic acid receptor rxr beta a | 0.001 | 0.0297 | 0.0297 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0044 | 0.6792 | 0.6792 |
Brugia malayi | ubiquitin conjugating enzyme protein 13 | 0.0037 | 0.5407 | 0.5267 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0037 | 0.5407 | 1 |
Entamoeba histolytica | ubiquitin-conjugating enzyme family protein | 0.0037 | 0.5407 | 0.5 |
Schistosoma mansoni | coup transcription factor | 0.001 | 0.0297 | 0.0297 |
Echinococcus granulosus | hepatocyte nuclear factor 4 alpha | 0.001 | 0.0297 | 0.0297 |
Schistosoma mansoni | steroid hormone receptor ad4bp | 0.001 | 0.0297 | 0.0297 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0037 | 0.5407 | 0.5 |
Onchocerca volvulus | Bile acid receptor homolog | 0.001 | 0.0297 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0044 | 0.6792 | 0.6792 |
Trypanosoma brucei | ubiquitin-protein ligase, putative | 0.0037 | 0.5407 | 0.5 |
Schistosoma mansoni | Tr4/Tr2 (homologue) | 0.001 | 0.0297 | 0.0297 |
Schistosoma mansoni | nuclear receptor 2DBD-gamma | 0.001 | 0.0297 | 0.0297 |
Echinococcus multilocularis | hepatocyte nuclear factor 4 alpha | 0.001 | 0.0297 | 0.0297 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.001 | 0.0297 | 0.0297 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
LD50 (ADMET) | = 162 mg kg-1 | Acute toxicity in ip dosed ICR mouse | ChEMBL. | 24445313 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.